Feasibility of Biodynamic Imaging for Predicting Therapeutic Effect in Metastatic Adenocarcinoma of the Pancreas

Sym015 (Anti-MET) in Patients With Advanced Solid Tumor Malignancies

Pilot Phase 2 Study Whole Brain Radiation Therapy With Simultaneous Integrated Boost for Patients With Brain Metastases

Carboplatin With or Without Atezolizumab in Treating Patients With Stage IV Triple Negative Breast Cancer

IBI308 in Subjects With Advanced/Metastatic Solid Malignancies

Brentuximab Vedotin in Relapsed/Refractory Germ Cell Tumors

PROCLAIM-CX-2009: A Trial to Find Safe and Active Doses of an Investigational Drug CX-2009 for Patients With Selected Solid Tumors

A Study of DSP-0509 in Patients With Advanced Solid Tumors to Determine the Safety and the Pharmacokinetic Profile

Study of Vosaroxin and Cytarabine for the Treatment of Adults 60 Years of Age or Older With Previously Untreated AML

Open-Label Extension and Safety Study of Talazoparib

iMETX (Individualized Metabolic RX): a Pilot Study

A Study of DSP-0337 in Patients With Advanced Solid Tumors to Determine the Safety and the Pharmacokinetic Profile

Tomivosertib (eFT-508) in Combination With PD-1/PD-L1 Inhibitor Therapy

Circulating Tumor Cells (CTC) in Lung Cancer

Sitagliptin for Prevention of Acute Graft Versus-Host Disease After Allogeneic Hematopoietic Stem Cell Transplantation

Pre-Operative Radiation and Veliparib for Breast Cancer

Partial Irradiation and Sequential vs. Concurrent Chemo Early Breast Cancer

Inhibiting Fatty Acid Synthase to Improve Efficacy of Neoadjuvant Chemotherapy

Intraoperative Folate Targeted Fluorescence in Renal Cell Carcinoma

Respiratory-gated Stereotactic Body Radiation Therapy for Adenocarcinoma of the Pancreas or Periampullary Region

Comparison of Operative to Monitoring and Endocrine Therapy (COMET) Trial For Low Risk DCIS

PhII Trial Panitumumab, Nivolumab, Ipilimumab in Kras/Nras/BRAF Wild-type MSS Refractory mCRC